The Journal of Korean Diabetes

Opinion
새로운 기전의 당뇨병 약제 Tirzepatide가 당뇨병 치료에 가져올 변화: 김수경; J Korean Diabetes. 2022;23(4):213-216.

Mounjaro® (tirzepatide) was approved by the U.S. Food and Drug Administration for type 2 diabetes treatment in August 2022. Tirzepatide, a synthetic peptide consisting of 39 amino acids, is a...

Statement
국내 진료 환경에서 자동 인슐린주입의 임상 적용: 진상만; J Korean Diabetes. 2022;23(4):217-221.

In contrast to Europe and the United States (US), conventional insulin pumps have not been widely used in East Asia, even among people with type 1 diabetes. Clinical experiences in...

Focused Issue
당뇨병말초신경병증의 병태생리와 치료: 강선미; J Korean Diabetes. 2022;23(4):222-229.

Diabetic neuropathy is the most common chronic complication of both type 1 and type 2 diabetes mellitus. Diabetic peripheral neuropathy (DPN), especially, distal symmetric polyneuropathy is the most common form...

Focused Issue
난치성 통증을 동반한 당뇨병말초신경병증의 관리: 문지연; J Korean Diabetes. 2022;23(4):230-237.

Peripheral neuropathy is one of the most common complications of both type 1 and type 2 diabetes. The most common diabetic neuropathy (DN) is distal symmetric polyneuropathy, with characteristic glove-...

Focused Issue
머신러닝 기법을 이용한 당뇨병신경병증의 예측: 현정근; J Korean Diabetes. 2022;23(4):238-244.

Peripheral polyneuropathy is one of the most common complications in patients with diabetes mellitus, and it results in neuropathic pain, falling tendency, and foot ulcers as well as sensory and...

Focused Issue
당뇨병신경병증과 심혈관질환 위험: 윤재승; J Korean Diabetes. 2022;23(4):245-250.

Neuropathy is a common complication of diabetes that can appear in the early stages of diabetes or even in the prediabetes stage. The relationship between autonomic neuropathy and cardiovascular disease...

Information Desk
우리나라 만성질환관리 변화에 대한 고찰: 이정림; J Korean Diabetes. 2022;23(4):251-257.

Globally, chronic diseases have a high burden and are a significant factor affecting society, such as through economic productivity and deepening social inequality. Deaths from chronic diseases in Korea accounted...

Information Desk
영양불량을 동반한 당뇨병환자의 임상영양요법: 김민지; J Korean Diabetes. 2022;23(4):258-261.

Recently, the prevalence of diabetic mellitus patients in Korea has been increasing, and it increasing with age. The treatment goal of diabetes is to prevent complications through blood sugar management,...

Information Desk
성인당뇨병 환자의 임상 교육 상담: 이제연; J Korean Diabetes. 2022;23(4):262-265.

Diabetes patients are steadily increasing. As such, the importance of diabetes education is being emphasized as the number of diabetic patients continues to increase. Diabetes education is being conducted by...

Original Article
당화혈색소 수준에 따른 보행 시 족압변인의 타당성: 이경옥, 강윤희, 홍영선, 권오란, 김재원, Yin-Zhu Jin; J Korean Diabetes. 2022;23(4):266-277.

The purpose of this study was to explore the variables of foot pressure according to glycated hemoglobin level during walking in diabetic patients with pes rectus. The subjects of this...

Case Report
COVID-19 감염 후 발생한 전격성 1형당뇨병 1예: 서동우, 이차곤, 이홍규, 김진택; J Korean Diabetes. 2022;23(4):278-281.

testing revealed that the patient was positive for HLA-DRB1*04, HLA-DRB1*12, HLA-DQB1*03, and HLA-DQB1*04. To the best of our knowledge, this is the first case of fulminant T1DM reported to occur immediately after...

Current Issue: Volume 23(4); Dec 2022

Opinion

새로운 기전의 당뇨병 약제 Tirzepatide가 당뇨병 치료에 가져올 변화: 김수경; J Korean Diabetes. 2022;23(4):213-216. Published online December 31, 2022; DOI: https://doi.org/10.4093/jkd.2022.23.4.213

Statement

국내 진료 환경에서 자동 인슐린주입의 임상 적용: 진상만; J Korean Diabetes. 2022;23(4):217-221. Published online December 31, 2022; DOI: https://doi.org/10.4093/jkd.2022.23.4.217

Focused Issues

당뇨병말초신경병증의 병태생리와 치료: 강선미; J Korean Diabetes. 2022;23(4):222-229. Published online December 31, 2022; DOI: https://doi.org/10.4093/jkd.2022.23.4.222

난치성 통증을 동반한 당뇨병말초신경병증의 관리: 문지연; J Korean Diabetes. 2022;23(4):230-237. Published online December 31, 2022; DOI: https://doi.org/10.4093/jkd.2022.23.4.230

머신러닝 기법을 이용한 당뇨병신경병증의 예측: 현정근; J Korean Diabetes. 2022;23(4):238-244. Published online December 31, 2022; DOI: https://doi.org/10.4093/jkd.2022.23.4.238

당뇨병신경병증과 심혈관질환 위험: 윤재승; J Korean Diabetes. 2022;23(4):245-250. Published online December 31, 2022; DOI: https://doi.org/10.4093/jkd.2022.23.4.245

Information Desks

우리나라 만성질환관리 변화에 대한 고찰: 이정림; J Korean Diabetes. 2022;23(4):251-257. Published online December 31, 2022; DOI: https://doi.org/10.4093/jkd.2022.23.4.251

영양불량을 동반한 당뇨병환자의 임상영양요법: 김민지; J Korean Diabetes. 2022;23(4):258-261. Published online December 31, 2022; DOI: https://doi.org/10.4093/jkd.2022.23.4.258

성인당뇨병 환자의 임상 교육 상담: 이제연; J Korean Diabetes. 2022;23(4):262-265. Published online December 31, 2022; DOI: https://doi.org/10.4093/jkd.2022.23.4.262

Original Article

당화혈색소 수준에 따른 보행 시 족압변인의 타당성: 이경옥, 강윤희, 홍영선, 권오란, 김재원, Yin-Zhu Jin; J Korean Diabetes. 2022;23(4):266-277. Published online December 31, 2022; DOI: https://doi.org/10.4093/jkd.2022.23.4.266

Case Report

COVID-19 감염 후 발생한 전격성 1형당뇨병 1예: 서동우, 이차곤, 이홍규, 김진택; J Korean Diabetes. 2022;23(4):278-281. Published online December 31, 2022; DOI: https://doi.org/10.4093/jkd.2022.23.4.278

Volume 23, No. 4

The Journal of
Korean Diabetes

Print ISSN: 2233-7431
Online ISSN: 2714-0547

MOST VIEWED

2,149	Recent Advances in Anti-Obesity Drugs
863	Tirzepatide, A New Antidiabetic Drug with Change in the Treatment of Patients with Type 2 Diabetes
846	Pathogenesis and Treatment of Diabetic Peripheral Neuropathy
1,801	Use of Dual-Energy X-ray Absorptiometry for Body Composition in Chronic Disease Management
3,106	Effects of Jerusalem Artichoke Extract and Inulin on Blood Glucose Levels and Insulin Secretion in Streptozotocin Induced Diabetic Mice

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr

Copyright © 2023 by Korean Diabetes Association. All rights reserved.

prev

next